| Autor: |
Jiawen Fong, Dawn Sinn Yii Chia, Darryl Ee Ming Chew, Kenneth Pak Leung Wong |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Annals, Academy of Medicine, Singapore, Vol 53, Iss 8, Pp 514-518 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2972-4066 |
| DOI: |
10.47102/annals-acadmedsg.202449 |
| Popis: |
The Bacillus Calmette–Guerin (BCG) vaccine, derived from wild-type Mycobacterium bovis, is administered in an attenuated form to prevent Mycobacterium tuberculous (MTB) infections in children residing in endemic regions. Since the introduction of the Singapore Tuberculosis Elimination Programme in 1997—specifying mandatory BCG-immunisation at birth—the incidence fell drastically to 32.6 per 100,000 population in 2021,1 with the paediatric population contributing 2.1% of infections.2 |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
